Victory for Lindfield meningitis vaccination campaigner

Carol and Anna Taylor SUS-150313-105543001
Carol and Anna Taylor SUS-150313-105543001

A meningitis survivor said she is ‘ecstatic’ every child over two months old will now have access to a life-saving vaccine.

Carol Taylor, from Lindfield, has backed a campaign to introduce a vaccine for meningococcal Group B (Men B) – one of the largest causes of meningitis in the UK.

She was diagnosed with group B meningococcal meningitis and septicaemia in 2007.

Carol was rushed to hospital after her daughter found her in bed in agony but went on to make a full recovery.

The government has announced it has reached a deal with GlaxoSmithKline and will be introduced on the NHS.

“I was just ecstatic to find out,” Carol told the Middy.

“We got an email through from the research foundation and then we heard.

“This is what we have been waiting for, for so long.

“This is just wonderful news.

“I’m delighted for all children who are new born. All the effort was worthwhile,” she added.

Carol said she was pleased for the families who had joined the campaign led by the Meningitis Research Foundation.

Chris Head, Chief Executive of Meningitis Research Foundation said: “MenB has been at the top of this charity’s agenda for decades and we are delighted that vaccinating all babies against this devastating disease is now within sight, cementing the UK’s position as a world leader in meningitis prevention.

“When this vaccine is finally introduced it will save lives and spare countless families the trauma of seeing a loved one die or become seriously disabled because of MenB.

“The bitter experience of those who have been personally affected has been vital in our campaigning for this vaccine, demonstrating the compelling case for prevention,” he added.